EXPIRED: Nevrargenics Ltd.
Nevrargenics is a drug discovery and development company working towards understanding, treating and reversing neurodegenerative diseases.
Our interests are widely across neurodegenerative diseases through a novel dual-acting small molecule, which may be valuable in treating a number of closely linked diseases, such as ALS, FTD and Alzheimer’s disease.
Currently raising funds via Envestors.
Financials
| Raising: | £1,500,000 |
| Tax: | EIS |
| Deadline: | 26-04-2022 |
The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested. Investors should carry out their own due diligence and take professional advice where necessary.
We act as an investment opportunity aggregator, collecting hundreds of investment opportunities from across the UK.
If you'd like your events, opportunities and news listed here please join free as an organisation.